K-numberK250946
Device nameDenture Base Resin DT20
ApplicantHangzhou SHINING3D Dental Technology Co., Ltd.
Product codeEBI
Device classClass II
Decision dateMar 31, 2025
DecisionSubstantially Equivalent
Regulation872.3760
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Denture Base Resin DT20 is a light-curable, liquid polymerizable resin used to fabricate full and partial removable dentures in dental laboratories. The material is polymerized using a 3D printer (AccuFab-D1s or AccuFab-C1s) and post-curing unit (FabCure 2), requiring a digital denture file to produce the final denture base.

Technological characteristics

Both subject and predicate devices are light-curable methacrylate-based resins used with additive manufacturing for denture fabrication. The key difference is that the subject device contains no filler material, whereas the predicate device includes filler; however, performance testing confirms the subject device meets the same mechanical property standards as the predicate through acrylate-based alternatives.

Test standards cited

ISO 20795-1:2013 (denture base polymers), ISO 7491:2000 (color stability), ISO 10993-1 (biocompatibility evaluation), ISO 7405 (denture base materials), and ASTM F1980-16 (shelf-life testing). Biocompatibility testing included cytotoxicity, sensitization, irritation, acute systemic toxicity, subacute/subchronic toxicity, implantation, pyrogenicity, and genotoxicity.

Substantial equivalence argument

The subject device is substantially equivalent because it shares the same intended use (fabrication of removable dentures), regulatory classification (Class II, product code EBI), material type (light-curable resin), and curing method (UV light) as the predicate. Although the subject device omits fillers present in the predicate, performance bench testing demonstrates it meets all applicable ISO 20795-1 standards for denture base polymers, and biocompatibility testing was more comprehensive, addressing potential safety gaps. The minor compositional difference raises no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →